Abiopharma

🔍 Waddill William D. (Director)

Company: Protagonist Therapeutics, Inc (PTGX)

Report Date: 2026-01-02

Detailed Transactions and Holdings:

• Acquired 2,695 shares of Common Stock (Direct)
  Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,825.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 3,762 shares of Stock Option (right to buy) at $87.18 per share (Derivative)
  Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 3,762.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date.
• F2: The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.